JP2023516300A5 - - Google Patents
Info
- Publication number
- JP2023516300A5 JP2023516300A5 JP2022551637A JP2022551637A JP2023516300A5 JP 2023516300 A5 JP2023516300 A5 JP 2023516300A5 JP 2022551637 A JP2022551637 A JP 2022551637A JP 2022551637 A JP2022551637 A JP 2022551637A JP 2023516300 A5 JP2023516300 A5 JP 2023516300A5
- Authority
- JP
- Japan
- Prior art keywords
- agonist
- population
- tils
- optionally
- tumor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062983416P | 2020-02-28 | 2020-02-28 | |
| US62/983,416 | 2020-02-28 | ||
| US202063074841P | 2020-09-04 | 2020-09-04 | |
| US63/074,841 | 2020-09-04 | ||
| US202163144853P | 2021-02-02 | 2021-02-02 | |
| US63/144,853 | 2021-02-02 | ||
| PCT/US2021/019861 WO2021173964A1 (en) | 2020-02-28 | 2021-02-26 | Methods for activation and expansion of tumor infiltrating lymphocytes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023516300A JP2023516300A (ja) | 2023-04-19 |
| JP2023516300A5 true JP2023516300A5 (https=) | 2024-01-26 |
Family
ID=77491997
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022551637A Pending JP2023516300A (ja) | 2020-02-28 | 2021-02-26 | 腫瘍浸潤リンパ球の活性化及び増殖のための方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230108584A1 (https=) |
| EP (1) | EP4110352A4 (https=) |
| JP (1) | JP2023516300A (https=) |
| KR (1) | KR20230034198A (https=) |
| CN (1) | CN116096865A (https=) |
| AU (1) | AU2021228701A1 (https=) |
| CA (1) | CA3168932A1 (https=) |
| WO (1) | WO2021173964A1 (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109536444B (zh) * | 2018-12-11 | 2022-06-28 | 吉林省拓华生物科技有限公司 | 一种适用于恶性实体瘤肿瘤浸润t淋巴细胞的分离诱导方法 |
| CA3158133A1 (en) | 2020-04-28 | 2021-11-04 | Lyell Immunopharma, Inc. | Methods for culturing cells |
| EP4239059A4 (en) | 2020-11-19 | 2024-05-15 | Suzhou Grit Biotechnology Co., Ltd. | METHOD FOR CULTIVATION OF TUMOR INFILTRATING LYMPHOCYTES AND USE THEREOF |
| US12144827B2 (en) | 2021-02-25 | 2024-11-19 | Lyell Immunopharma, Inc. | ROR1 targeting chimeric antigen receptor |
| CN117043321A (zh) * | 2021-04-23 | 2023-11-10 | 苏州沙砾生物科技有限公司 | 一种修饰的肿瘤浸润淋巴细胞及其用途 |
| JP2024547000A (ja) * | 2021-12-17 | 2024-12-26 | インスティル バイオ インコーポレイテッド | 腫瘍浸潤リンパ球の処理 |
| CN118414422A (zh) * | 2021-12-30 | 2024-07-30 | 苏州沙砾生物科技有限公司 | 一种修饰的肿瘤浸润淋巴细胞及其用途 |
| WO2023143515A1 (zh) * | 2022-01-29 | 2023-08-03 | 苏州沙砾生物科技有限公司 | 一种修饰的肿瘤浸润淋巴细胞及其用途 |
| WO2024020531A1 (en) * | 2022-07-21 | 2024-01-25 | Tract Therapeutics, Inc. | Immune cell expansion and uses thereof |
| EP4694917A1 (en) * | 2023-04-12 | 2026-02-18 | Beam Therapeutics Inc. | Modified immune effector cells with improved efficacy |
| CN117417894A (zh) * | 2023-09-15 | 2024-01-19 | 毕诺济(上海)生物技术有限公司 | 敲除Roquin-1和/或Regnase-1基因的肿瘤浸润淋巴细胞及其应用 |
| WO2025092690A1 (zh) * | 2023-10-30 | 2025-05-08 | 苏州沙砾生物科技有限公司 | 一种修饰的细胞及其用途 |
| WO2025096638A2 (en) * | 2023-10-30 | 2025-05-08 | Turnstone Biologics Corp. | Genetically modified tumor infilitrating lymphocytes and methods of producing and using the same |
| WO2025106513A1 (en) * | 2023-11-13 | 2025-05-22 | KSQ Therapeutics, Inc. | Methods for producing edited tumor infiltrating lymphocytes |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2711418B1 (en) * | 2012-09-25 | 2017-08-23 | Miltenyi Biotec GmbH | Method for polyclonal stimulation of T cells by flexible nanomatrices |
| EP2961415B1 (en) * | 2013-03-01 | 2021-01-06 | The United States of America, as represented by The Secretary, Department of Health and Human Services | Methods of producing enriched populations of tumor-reactive t cells from tumor |
| WO2015157636A1 (en) * | 2014-04-10 | 2015-10-15 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Enhanced expansion of tumor-infiltrating lymphocytes for adoptive cell therapy |
| EP3322424B1 (en) * | 2015-07-16 | 2023-10-11 | Yeda Research and Development Co., Ltd. | Use of anti third party central memory t cells |
| KR20180063320A (ko) * | 2015-10-20 | 2018-06-11 | 카이트 파마 인코포레이티드 | T 세포 요법을 위한 t 세포를 제조하는 방법 |
| MX2019007963A (es) * | 2017-01-06 | 2019-10-21 | Iovance Biotherapeutics Inc | Expansion de linfocitos infiltrantes de tumor (til) con agonistas de la superfamilia de recptor de factor de necrosis tumoral (tnfrsf) y combinaciones terapeuticas de til- y agonistas de tnfrsf. |
| KR20200003913A (ko) * | 2017-05-10 | 2020-01-10 | 이오반스 바이오테라퓨틱스, 인크. | 액상 종양으로부터의 종양 침윤 림프구의 확장 및 그의 치료 용도 |
| CR20200251A (es) * | 2017-11-17 | 2020-07-17 | Iovance Biotherapeutics Inc | Expansión de til de aspirados con aguja fina y biopsias por punción |
| US20190284553A1 (en) * | 2018-03-15 | 2019-09-19 | KSQ Therapeutics, Inc. | Gene-regulating compositions and methods for improved immunotherapy |
-
2021
- 2021-02-26 KR KR1020227030600A patent/KR20230034198A/ko active Pending
- 2021-02-26 US US17/802,080 patent/US20230108584A1/en active Pending
- 2021-02-26 CN CN202180031516.0A patent/CN116096865A/zh active Pending
- 2021-02-26 JP JP2022551637A patent/JP2023516300A/ja active Pending
- 2021-02-26 WO PCT/US2021/019861 patent/WO2021173964A1/en not_active Ceased
- 2021-02-26 AU AU2021228701A patent/AU2021228701A1/en active Pending
- 2021-02-26 EP EP21760177.2A patent/EP4110352A4/en active Pending
- 2021-02-26 CA CA3168932A patent/CA3168932A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023516300A5 (https=) | ||
| US12371663B2 (en) | Engineered γδ T-cells | |
| JP2023502780A5 (https=) | ||
| Rossig et al. | Vaccination to improve the persistence of CD19CAR gene-modified T cells in relapsed pediatric acute lymphoblastic leukemia | |
| EP3927370B1 (en) | Methods for producing autologous t cells useful to treat cancers and compositions thereof | |
| TW202146441A (zh) | 製備表現嵌合抗原受體的細胞之方法 | |
| CN111373260A (zh) | 产生调节性免疫细胞的方法及其用途 | |
| JP2023501617A5 (https=) | ||
| JP7043114B2 (ja) | 細胞を活性化させるための方法およびキット | |
| CN115835873A (zh) | 用于产生表达重组受体的供体分批细胞的方法 | |
| WO2023250433A2 (en) | Engineered human t cells comprising a switchable chimeric antigen cell surface receptor and methods for generating them | |
| WO2020191378A1 (en) | METHODS FOR ENHANCING TCRαβ+ CELL DEPLETION EFFICIENCY | |
| AU2020240339B2 (en) | Methods for enhancing TCRαβ+ cell depletion efficiency | |
| EP2201103B1 (fr) | Traitement de tumeurs par des preparations de lymphocytes t | |
| EP4295860A1 (en) | Engineered human t cells comprising a switchable chimeric antigen cell surface receptor and methods for generating them | |
| RU2829624C2 (ru) | СПОСОБЫ ПОВЫШЕНИЯ ЭФФЕКТИВНОСТИ ИСТОЩЕНИЯ TCRαβ+ КЛЕТОК | |
| SG11202110164YA (en) | Cd28 t cell cultures, compositions, and methods of using thereof | |
| HK40067810A (en) | Methods for enhancing tcr alpha beta+ cell depletion efficiency | |
| HK40067810B (en) | Methods for enhancing tcr alpha beta+ cell depletion efficiency | |
| HK40128957A (zh) | 体外衍生的t细胞群体、其生成方法及使用方法 | |
| HK40066864B (en) | Methods for producing autologous t cells useful to treat cancers and compositions thereof | |
| Martin | Adoptive T Cell Therapy of Breast Cancer: Defining and Circumventing Barriers to T Cell Infiltration in the Tumour Microenvironment | |
| HK1242585B (en) | Engineered gamma delta t-cells | |
| HK1242585A1 (en) | Engineered gamma delta t-cells |